Device typeCancer antigen 15-3 (CA15-3) IVD, kit, chemiluminescent immunoassay: A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 15-3 (CA15-3), a marker commonly associated with breast cancer, in a clinical specimen using a chemiluminescent immunoassay method.
FDA categorySYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR
Device ID00380740145330
Catalog number02K4437
AvailabilityPrescription
MRI safetyLabeling does not contain MRI Safety Information